{
  "ticker": "ABVX",
  "company_name": "Abivax SA",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02249988",
      "title": "Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Chronic Hepatitis B",
      "start_date": "2014-12",
      "completion_date": "2016-12",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT02990325",
      "title": "A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "HIV Infections, Health Volunteers",
      "start_date": "2017-03-27",
      "completion_date": "2019-10-21",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT05507203",
      "title": "ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Ulcerative Colitis",
      "start_date": "2022-10-10",
      "completion_date": "2025-06-25",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT05121714",
      "title": "Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2020-12-17",
      "completion_date": "2021-05-18",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT03368118",
      "title": "Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Ulcerative Colitis",
      "start_date": "2018-01-20",
      "completion_date": "2022-08-15",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT03905109",
      "title": "Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients",
      "status": "WITHDRAWN",
      "phase": "PHASE2, PHASE3",
      "condition": "Crohn Disease",
      "start_date": "2022-09-19",
      "completion_date": "2022-09-19",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT02731885",
      "title": "Food Effect on Pharmacokinetic Parameters of ABX464",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2014-09",
      "completion_date": "2015-06",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT03813199",
      "title": "Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2019-07-04",
      "completion_date": "2021-04-27",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT04023396",
      "title": "Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Ulcerative Colitis",
      "start_date": "2020-01-13",
      "completion_date": "2024-03-15",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    },
    {
      "nct_id": "NCT03897543",
      "title": "ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Carcinoma, Hepatocellular",
      "start_date": "2019-08-30",
      "completion_date": "2023-06-30",
      "enrollment": 0,
      "sponsor": "Abivax S.A."
    }
  ],
  "summary": {
    "total_trials": 22,
    "by_phase": {
      "PHASE2, PHASE3": 3,
      "PHASE1, PHASE2": 2,
      "PHASE3": 3,
      "PHASE1": 4,
      "PHASE2": 10
    },
    "by_status": {
      "COMPLETED": 16,
      "WITHDRAWN": 1,
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 2,
      "TERMINATED": 1
    },
    "active_trials": 4,
    "completed_trials": 16,
    "conditions": [
      "COVID-19",
      "Carcinoma, Hepatocellular",
      "Chronic Hepatitis B",
      "Crohn Disease",
      "HIV Infection",
      "HIV Infections, Health Volunteers",
      "Healthy",
      "Healthy Volunteers",
      "Human Immunodeficiency Virus Infections",
      "Moderately to Severely Active Crohn Disease",
      "Rheumatoid Arthritis",
      "Ulcerative Colitis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:15:54.519321",
    "search_query": "Abivax SA",
    "url": "https://clinicaltrials.gov/search?term=Abivax+SA"
  }
}